Chakma Justin Insider Trades

Insider Trading History

Track insider trading activity for Chakma Justin. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Business Officer
Holding Value $2.18M 240,000 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.76M 240,000 shares
$11.49
$9.07
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Business Officer
Holding Value $1.51M 166,380 shares
Last Trade
Nov 12, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$268k 30,000 shares
$8.94
$9.07
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Business Officer
Holding Value $1.24M 136,380 shares
Last Trade
Nov 12, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.48M 166,380 shares
$8.87
$9.07
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Business Officer
Holding Value $808k 89,047 shares
Last Trade
Nov 12, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$268k 30,000 shares
$8.94
$9.07
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Business Officer
Holding Value $2.49M 274,100 shares
Last Trade
Jan 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.94M 274,100 shares
$10.71
$9.07
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Business Officer
Holding Value $503k 55,461 shares
Last Trade
Dec 13, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$325k 27,272 shares
$11.90
$9.07
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Business Officer
Holding Value $1.48M 163,652 shares
Last Trade
Dec 13, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$325k 27,272 shares
$11.90
$9.07
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Business Officer
Holding Value $1.24M 136,380 shares
Last Trade
Dec 13, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$329k 27,272 shares
$12.06
$9.07
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Business Officer
Holding Value $1.24M 136,380 shares
Last Trade
Dec 12, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.44M 117,333 shares
$12.27
$9.07
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Business Officer
Holding Value $2.3M 253,713 shares
Last Trade
Dec 12, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.48M 117,333 shares
$12.64
$9.07
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Business Officer
Holding Value $1.08M 119,047 shares
Last Trade
Dec 12, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.48M 117,333 shares
$12.64
$9.07
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Business Officer
Holding Value $0 0 shares
Last Trade
Dec 10, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$648k 50,000 shares
$12.95
$9.07
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Business Officer
Holding Value $1.24M 136,380 shares
Last Trade
Dec 10, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$658k 50,000 shares
$13.15
$9.07
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Business Officer
Holding Value $1.69M 186,380 shares
Last Trade
Dec 10, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$648k 50,000 shares
$12.95
$9.07
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Business Officer
Holding Value $454k 50,000 shares
Last Trade
Dec 06, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$701k 50,000 shares
$14.02
$9.07
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Business Officer
Holding Value $1.69M 186,380 shares
Last Trade
Dec 06, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$701k 50,000 shares
$14.02
$9.07
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Business Officer
Holding Value $1.24M 136,380 shares
Last Trade
Dec 06, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$712k 50,000 shares
$14.23
$9.07
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Business Officer
Holding Value $1.24M 136,380 shares
Last Trade
Dec 05, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$701k 49,640 shares
$14.13
$9.07
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Business Officer
Holding Value $907k 100,000 shares
Last Trade
Dec 05, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$695k 49,640 shares
$14.00
$9.07
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Business Officer
Holding Value $1.69M 186,020 shares
Last Trade
Dec 05, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$695k 49,640 shares
$14.00
$9.07

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up